Tower Research Capital (TRC)’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,501
| Closed | -$3.25K | – | 5503 |
|
|
2025
Q1 | $3.25K | Sell |
2,501
-2,181
| -47% | -$2.84K | ﹤0.01% | 4445 |
|
|
2024
Q4 | $8.43K | Buy |
4,682
+3,508
| +299% | +$6.32K | ﹤0.01% | 3995 |
|
|
2024
Q3 | $4.05K | Buy |
1,174
+537
| +84% | +$1.85K | ﹤0.01% | 4700 |
|
|
2024
Q2 | $3.97K | Buy |
637
+4
| +0.6% | +$25 | ﹤0.01% | 4838 |
|
|
2024
Q1 | $3.87K | Sell |
633
-2
| -0.3% | -$12 | ﹤0.01% | 4777 |
|
|
2023
Q4 | $4.34K | Buy |
635
+412
| +185% | +$2.82K | ﹤0.01% | 4965 |
|
|
2023
Q3 | $3.03K | Buy |
223
+76
| +52% | +$1.03K | ﹤0.01% | 5064 |
|
|
2023
Q2 | $3.8K | Buy |
+147
| New | +$3.8K | ﹤0.01% | 4998 |
|
|
2023
Q1 | – | Sell |
-48
| Closed | -$2K | – | 6177 |
|
|
2022
Q4 | $2K | Sell |
48
-3
| -6% | -$125 | ﹤0.01% | 5406 |
|
|
2022
Q3 | $3K | Sell |
51
-25
| -33% | -$1.47K | ﹤0.01% | 5412 |
|
|
2022
Q2 | $6K | Buy |
+76
| New | +$6K | ﹤0.01% | 4941 |
|
|
2021
Q3 | – | Sell |
-6
| Closed | -$2K | – | 6064 |
|
|
2021
Q2 | $2K | Buy |
+6
| New | +$2K | ﹤0.01% | 5064 |
|
|
2020
Q4 | – | Sell |
-5
| Closed | -$1K | – | 5348 |
|
|
2020
Q3 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 4722 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4229 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 4141 |
|
|
2016
Q4 | – | Hold |
0
| – | -$1K | – | 4267 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 3343 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4730 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4925 |
|
|
2015
Q1 | – | Hold |
0
| – | -$5K | – | 4817 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 2736 |
|
|
2014
Q3 | – | Hold |
0
| – | -$5K | – | 4795 |
|
|
2014
Q2 | – | Hold |
0
| – | -$18K | – | 2868 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 2010 |
|